Related Experiment Videos
The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart
D K Cooper1, D Novitzky, W N Wicomb
1Department of Cardiothoracic Surgery, Groote Schuur Hospital, Cape Town, South Africa.
Insights
Brain death causes hormonal depletion, impairing mitochondrial function and organ energy. Hormone replacement therapy, particularly triiodothyronine (T3), restores energy stores and organ function, improving outcomes for organ donors.
Area of Science:
- Physiology
- Endocrinology
- Transplantation Medicine
Background:
- Brain death triggers significant physiological changes, including myocardial and pulmonary injury.
- Hormonal depletion during brain death inhibits mitochondrial function and reduces aerobic metabolism.
- Diminished organ energy stores lead to widespread functional deterioration.
Purpose of the Study:
- To investigate the role of hormonal depletion in brain death-induced organ dysfunction.
- To evaluate the efficacy of hormone replacement therapy in restoring organ function in brain-dead individuals.
- To assess the impact of hormonal therapy on organ viability and post-transplantation outcomes.
Main Methods:
- Monitoring electrocardiographic, hemodynamic, and histopathological changes.
- Assessing circulating hormone levels and mitochondrial function.
- Administering hormone replacement therapy (T3, cortisol, insulin) to brain-dead potential organ donors.
Main Results:
- Hormonal depletion was confirmed, leading to inhibited mitochondrial activity and reduced aerobic metabolism.
- Hormone replacement therapy rapidly replenished organ energy stores and restored normal function.
- Triiodothyronine (T3) alone reactivated mitochondria and stimulated aerobic metabolism.
- Hormonal therapy resulted in metabolic and hemodynamic stability in organ donors.
Conclusions:
- Hormonal therapy is crucial for reversing brain death-induced organ damage.
- Restoration of hormone levels improves organ energy stores and function, crucial for transplantation.
- Hormonal treatment enhances organ viability, prevents wastage, and improves transplant success rates.
Abstract:
Major electrocardiographic, haemodynamic, and histopathological changes take place during the development of brain death; myocardial and pulmonary injury may result. Significant depletion of certain circulating hormones occurs, resulting in an inhibition of mitochondrial function, leading to reduced aerobic metabolic oxidative processes, affecting the body as a whole. Major organ energy stores are therefore diminished, leading to deterioration of function. Replacement of the depleted hormones, in particular triiodothyronine (T3), cortisol, and insulin, leads to rapid replacement of organ energy stores, associated with a return to normal function. T3 alone leads to reactivation of the mitochondria, stimulating aerobic metabolism. Hormonal therapy to brain-dead potential organ donors has been shown to lead to metabolic and haemodynamic stability, resulting in no wastage of organs, and in improved function after transplantation.